Covid mRNA tech could create first-ever cure for heart attacks: UK scientists

British scientists may have discovered the world’s first cure for heart attacks using the same mRNA technology as Covid vaccines.

The human heart does not have the ability to heal itself after a heart attack.

But with the new technique called genetic tracking – based on the same technology used to create Covid vaccines from Pfizer and Moderna – can help new heart cells replace dead cells and instead of scarring, grow new muscle tissue. .

A team from King’s College London tracked genetic codes called mRNAs that are injected into the heart to produce proteins that would generate healthy heart cells, Daily Mail reported.

“We are all born with a set number of muscle cells in our heart and these are the exact same ones we will die with. Our goal has been to find a treatment that can convince surviving cells to proliferate,” said lead researcher Dr. Professor Mauro Giacca. quoted as saying.

“Regenerating a damaged human heart was a dream until a few years ago, but can now become a reality.

“We use the exact same technology as the Pfizer and Moderna vaccines to inject microRNAs into the heart, reaching surviving heart cells and pushing them to proliferate,” Giacca said.

In addition to helping hearts regenerate, mRNAs also work towards a treatment to prevent cells from dying in a heart attack.

Heart attacks and strokes accounted for 85% of the 17.9 million deaths from cardiovascular disease worldwide.

Scientists believe the new RNA (ribonucleic acid) therapy could revolutionize cardiovascular medicine and prevent millions of heart attacks from progressing to heart failure, according to the report.

The technology first tested to regenerate damaged pig hearts has so far been successful. Human trials are expected within the next two years.

(Only the title and image of this report may have been edited by Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear reader,

Business Standard has always endeavored to provide up-to-date information and commentary on developments that matter to you and that have wider political and economic implications for the country and the world. Your constant encouragement and feedback on how to improve our offering has only strengthened our resolve and commitment to these ideals. Even in these challenging times stemming from Covid-19, we remain committed to keeping you informed and up-to-date with credible news, authoritative opinions and incisive commentary on relevant topical issues.
However, we have a request.

As we battle the economic impact of the pandemic, we need your support even more so that we can continue to bring you more great content. Our subscription model has received an encouraging response from many of you who have subscribed to our online content. More subscriptions to our online content can only help us achieve the goals of bringing you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practice the journalism we are committed to.

Support quality journalism and subscribe to Business Standard.

digital editor

Source link

Edward L. Robinett